Wells Fargo & Company Inovio Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.35 - $0.53 $1,093 - $1,655	3,124 Added 16.69%	21,847 $11,000
Q3 2023 Nov 13, 2023	SELL	$0.38 - $0.58 $750 - $1,145	-1,975 Reduced 9.54%	18,723 $7,000
Q2 2023 Aug 15, 2023	SELL	$0.39 - $0.94 $164,816 - $397,249	-422,606 Reduced 95.33%	20,698 $9,000
Q1 2023 May 12, 2023	BUY	$0.79 - $1.91 $334,707 - $809,228	423,680 Added 2158.99%	443,304 $363,000
Q4 2022 Feb 13, 2023	SELL	$1.41 - $2.5 $21,460 - $38,050	-15,220 Reduced 43.68%	19,624 $30,000
Q3 2022 Nov 14, 2022	SELL	$1.66 - $2.79 $9,900 - $16,639	-5,964 Reduced 14.61%	34,844 $60,000
Q2 2022 Aug 12, 2022	SELL	$1.44 - $3.98 $83,217 - $230,004	-57,790 Reduced 58.61%	40,808 $71,000
Q1 2022 May 16, 2022	SELL	$2.97 - $5.2 $425,820 - $745,544	-143,374 Reduced 59.25%	98,598 $354,000
Q4 2021 Feb 14, 2022	BUY	$4.99 - $7.46 $231,106 - $345,502	46,314 Added 23.67%	241,972 $1.21 Million
Q3 2021 Nov 15, 2021	BUY	$7.16 - $9.69 $492,429 - $666,429	68,775 Added 54.2%	195,658 $1.4 Million
Q2 2021 Aug 16, 2021	BUY	$6.23 - $10.03 $43,429 - $69,919	6,971 Added 5.81%	126,883 $1.18 Million
Q1 2021 May 13, 2021	SELL	$8.81 - $16.96 $2.62 Million - $5.04 Million	-297,177 Reduced 71.25%	119,912 $1.11 Million
Q4 2020 Feb 09, 2021	BUY	$8.5 - $12.85 $241,408 - $364,952	28,401 Added 7.31%	417,089 $3.69 Million
Q3 2020 Nov 05, 2020	SELL	$9.57 - $27.05 $231,584 - $654,582	-24,199 Reduced 5.86%	388,688 $4.51 Million
Q2 2020 Aug 13, 2020	BUY	$7.14 - $31.69 $2.36 Million - $10.5 Million	330,995 Added 404.18%	412,887 $11.1 Million
Q1 2020 May 14, 2020	BUY	$2.98 - $14.09 $244,038 - $1.15 Million	81,892 New	81,892 $609,000

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.41B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account